Related Experiment Video
Updated: Jun 28, 2026

Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions
Published on: April 3, 2014
Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration
1Cardiology Division, Center for Molecular Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, New York, NY, USA.
Background:
Rapamycin is a potent inhibitor of smooth muscle cell (SMC) proliferation and migration. Rapamycin-mediated inhibition of SMC proliferation is associated with upregulation of the cyclin-dependent kinase inhibitor p27(Kip1). Previously, we showed that mixed embryonic fibroblasts obtained from p27(Kip1)(-/-) mice were relatively rapamycin-resistant, suggesting that p27(Kip1) plays an integral role in modulating the antiproliferative effects of rapamycin. We hypothesized that the antimigratory effect of rapamycin may also be mediated by p27(Kip1).
Methods And Results:
Rapamycin (1 to 10 nmol/L) inhibited basic fibroblast growth factor-induced migration of wild-type (WT) but not p27(Kip1)(-/-) SMCs in a dose-dependent manner (P<0.05) in a modified Boyden chamber. The effects of rapamycin on aortic SMC explant migration were also studied with WT, p27(+/-), and p27(-/-) mice. Rapamycin 4 mg. kg(-1). d(-1) IP for 5 days inhibited SMC migration by 90% in the WT and p27(Kip1)(+/-) (P<0.05) but not p27(Kip1)(-/-) animals.
Conclusions:
Lack of p27(Kip1) reduces rapamycin-mediated inhibition of SMC migration. These novel findings suggest a role for p27(Kip1) in the signaling pathway(s) that regulates SMC migration.
Insights
The cyclin-dependent kinase inhibitor p27(Kip1) is crucial for rapamycin's ability to inhibit smooth muscle cell migration. Its absence significantly reduces rapamycin's antimigratory effects, highlighting its role in regulating cell movement.
Area of Science:
- Vascular Biology
- Cell Signaling
- Pharmacology
Background:
- Rapamycin inhibits smooth muscle cell (SMC) proliferation and migration.
- SMC proliferation inhibition by rapamycin involves p27(Kip1) upregulation.
- p27(Kip1) plays a role in rapamycin's antiproliferative effects.
Purpose of the Study:
- To investigate the role of p27(Kip1) in mediating the antimigratory effects of rapamycin on SMCs.
- To determine if p27(Kip1) is essential for rapamycin-induced inhibition of SMC migration.
Main Methods:
- Assessing rapamycin's effect on basic fibroblast growth factor-induced SMC migration in wild-type (WT) and p27(Kip1)(-/-) cells using a modified Boyden chamber.
- Evaluating rapamycin's impact on aortic SMC explant migration in WT, p27(+/-), and p27(-/-) mice.
Main Results:
- Rapamycin dose-dependently inhibited WT SMC migration but not p27(Kip1)(-/-) SMC migration.
- Systemic rapamycin administration significantly inhibited SMC migration in WT and p27(Kip1)(+/-) mice by 90%.
- p27(Kip1)(-/-) mice showed no significant inhibition of SMC migration in response to rapamycin.
Conclusions:
- The absence of p27(Kip1) diminishes the inhibitory effect of rapamycin on SMC migration.
- p27(Kip1) is implicated in the signaling pathways governing SMC migration.
- p27(Kip1) is a key mediator of rapamycin's antimigratory action on smooth muscle cells.
Related Concept Videos
Cell Migration
Cytoskeletal Linker Proteins - Plakins
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Cancer Cell Migration through Invadopodia
Mechanism of Lamellipodia Formation
Regulation of Angiogenesis and Blood Supply

